Guanfacine for Children with Tic Disorders
What is the purpose of this trial?
The Yale Child Study Center is recruiting subjects for a study of a new extended-release form of guanfacine (Intuniv®) in the treatment of tics in children with a Chronic Tic Disorder.
- 6 Years - 16 Years
- Shire Pharmaceuticals
- March 2012 - September 2013
- Last Updated:
- Study HIC#:
Clinicaltrials.gov ID: Yale6138683